Global Market Opportunities in the Molecular Diagnostics Devices and Equipment Market 2030: COVID-19 Implications and Growth – ResearchAndMarkets.com

Global Market Opportunities in the Molecular Diagnostics Devices and Equipment Market 2030: COVID-19 Implications and Growth – ResearchAndMarkets.com




Global Market Opportunities in the Molecular Diagnostics Devices and Equipment Market 2030: COVID-19 Implications and Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Molecular Diagnostics Devices and Equipment Global Market Opportunities and Strategies to 2030: COVID-19 Implications and Growth” report has been added to ResearchAndMarkets.com’s offering.

The global molecular diagnostics devices and equipment market reached a value of nearly $18,074.7 million in 2020, having increased at a compound annual growth rate (CAGR) of 26.0% since 2015. The market is expected to grow from $18,074.7 million in 2020 to $19,011.3 million in 2025 at a rate of 1.0%. The market is then expected to grow at a CAGR of 6.9% from 2025 and reach $26,508.0 million in 2030.

Growth in the historic period resulted from rise in funding, increase in healthcare expenditure, economic growth in emerging markets, rapid technological advances, emergence of novel pathogenic infestations, and rapid growth in geriatric population. The market was restrained by political uncertainties, regulatory challenges, reduction in free trade, and low healthcare reimbursements.

Going forward a rapid rise in various bacterial and viral epidemics, aging population, increase in healthcare access, rising prevalence of chronic diseases and increasing demand for molecular diagnostic devices and equipment due to COVID-19 will drive the growth. Factors that could hinder the growth of the molecular diagnostics devices and equipment market in the future include lack of well-defined regulatory framework, ethical concerns related to genomic study, high costs of tests and lack of skilled/trained molecular biologists.

North America was the largest region in the global molecular diagnostics devices and equipment market, accounting for 34.5% of the total in 2020. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the molecular diagnostics devices and equipment market will be South America and Eastern Europe, where growth will be at CAGRs of 4.1% and 3.8% respectively. These will be followed by Africa and Middle East where the markets are expected to grow at CAGRs of 3.7% and 3.1% respectively.

The top opportunities in the molecular diagnostics devices and equipment market segmented by product will arise in the reagents and consumables segment, which will gain $610.6 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by end-user will arise in the diagnostic laboratories segment, which will gain $530.6 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by technology will arise in the DNA sequencing segment, which will gain $304.7 million of global annual sales by 2025. The top opportunities in the molecular diagnostics devices and equipment market segmented by application will arise in the genetic testing segment, which will gain $345.8 million of global annual sales by 2025. The molecular diagnostics devices and equipment market size will gain the most in the Japan at $171.3 million.

Key Topics Covered:

  • Molecular Diagnostics Devices and Equipment Market Executive Summary
  • Molecular Diagnostics Devices and Equipment Market Characteristics
  • Molecular Diagnostics Devices and Equipment Market Trends and Strategies
  • Impact Of COVID-19 On The Molecular Diagnostics Devices and Equipment Market
  • Global Molecular Diagnostics Devices and Equipment Market Size and Growth
  • Global Molecular Diagnostics Devices and Equipment Market Segmentation
  • Molecular Diagnostics Devices and Equipment Market, Regional and Country Analysis
  • Asia-Pacific Molecular Diagnostics Devices and Equipment Market
  • Western Europe Molecular Diagnostics Devices and Equipment Market
  • Eastern Europe Molecular Diagnostics Devices and Equipment Market
  • North America Molecular Diagnostics Devices and Equipment Market
  • South America Molecular Diagnostics Devices and Equipment Market
  • Middle East Molecular Diagnostics Devices and Equipment Market
  • Africa Molecular Diagnostics Devices and Equipment Market
  • Global Molecular Diagnostics Devices and Equipment Market Competitive Landscape
  • Key Mergers and Acquisitions In The Molecular Diagnostics Devices and Equipment Market
  • Molecular Diagnostics Devices and Equipment Market Future Outlook and Potential Analysis

Companies Mentioned

  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Hologic
  • Abbott Laboratories
  • Danaher Corporation
  • Biomerieux
  • Becton, Dickinson & Co
  • Siemens Healthineers AG
  • Grifols, S.A.
  • Sysmex Corporation
  • Biocartis
  • Bio-Techne India Private Limited
  • Bio-Rad laboratories India Pvt.Ltd
  • Cleaver Scientific
  • QuantuMDx
  • Interlabservis
  • GeneMe
  • TestLine Clinical Diagnostics s.r.o.
  • Johnson & Johnson
  • Illumina, Inc.
  • Novartis AG
  • Cepheid, Inc.
  • Ortho Clinical Diagnostics, Inc
  • Beckman Coulter Inc.
  • Thermo Fisher Scientific
  • Grifols International S.A.

For more information about this report visit https://www.researchandmarkets.com/r/nge84r

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900